Impact of tumor size by clinical N subclassification and histology in trimodality-treated N2 non-small cell lung cancer

Impact of tumor size by clinical N subclassification and histology in trimodality-treated N2 non-small cell lung cancer

Abstract The evolving TNM classification has emphasized the tumor size’s role in NSCLC prognosis, reclassifying stage IIIA patients from the previous edition as stage IIIB (T3-4N2M0, 8th edition). However, the prognostic implications of tumor size and survival in stage III NSCLC patients undergoing...

Full description

Saved in:
Bibliographic Details
Main Authors: Junghee Lee, Jin Lee, Yun Soo Hong, Genehee Lee, Jiyoun Park, Yeong Jeong Jeon, Seong-Yong Park, Jong Ho Cho, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Eliseo Guallar, Juhee Cho, Hong Kwan Kim
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Tumor size
N2
Neoadjuvant
Non-small cell lung cancer
Trimodality therapy
Surgery
Online Access:https://doi.org/10.1038/s41598-024-82946-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-82946-y

Similar Items